With people of minority background and those with obesity and diabetes most at risk for severe cases of COVID-19, the National Institute of Diabetes and Digestive and Kidney Diseases is leading in the research behind why that is. Director Dr. Griffin Rodgers, who contributed to the first effective therapy for sickle cell anemia, updates HealthCast on the institute’s work to lessen the effects of COVID-19 on its research community, as well as other top research and data initiatives at the institution.
HealthCast
Season 2
Episode 17
21m listen
How One NIH Institute is Combating COVID-19 and Health Disparities
NIDDK Director Dr. Griffin Rodgers talks COVID-19, disparities in health, and top priorities at the institute.
-
Dr. Griffin Rodgers Director NIDDK
Related Content
-
VA Rolls Out Tele-emergency Care Program Nationwide
The Department of Veterans Affairs announced the roll out of its tele-emergency care program nationwide this week.
4m read -
DHA Official: Optimization is 'Future' of Federal EHR
Defense Healthcare Management Systems Program Officer Dr. Yvette Weber says usable information across health systems is key to clinical care.
5m read -
Respect, Collaboration Critical to Federal Health Grants Funding
Health IT leaders spoke about the critical, but often misunderstood role that grants funding drives in delivering better health outcomes for patients and clinicians.
3m read -
Advanced Computing Holds Promise for Health Care, Ethical Hurdles Remain
Researchers and government officials are creating policies to improve customer experience nearly a year after President Biden’s executive order on digital experience.
3m read
